Abstract
There are currently no effective treatments to halt the muscle breakdown in Duchenne muscular dystrophy (DMD), although genetic-based clinical trials are being piloted. Most of these trials have as an endpoint the restoration of dystrophin in muscle fibers, hence requiring sufficiently well-preserved muscle of recruited patients. The choice of the muscles to be studied and the role of noninvasive methods to assess muscle preservation therefore require further evaluation.
| Original language | English |
|---|---|
| Pages (from-to) | 346-353 |
| Number of pages | 8 |
| Journal | Neurology |
| Volume | 76 |
| DOIs | |
| Publication status | Published - 2011 |
Keywords
- Adolescent
- Child
- Foot
- Humans
- Leg
- Magnetic Resonance Imaging
- Male
- Muscle, Skeletal
- Muscular Dystrophy, Duchenne
Fingerprint
Dive into the research topics of 'Muscle histology vs MRI in Duchenne muscular dystrophy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver